{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:57:03Z","timestamp":1781013423414,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":927,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Clinical Research Center for Ischemic Heart Disease","award":["A040152"],"award-info":[{"award-number":["A040152"]}]},{"name":"Innovative Research Institute for Cell Therapy","award":["A062260"],"award-info":[{"award-number":["A062260"]}]},{"name":"Ministry of Health, Welfare & Family"},{"name":"World Class University program of the Ministry of Education and Science"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jacc.2010.08.631","type":"journal-article","created":{"date-parts":[[2011,1,12]],"date-time":"2011-01-12T05:42:40Z","timestamp":1294810960000},"page":"280-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":166,"title":["Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease"],"prefix":"10.1016","volume":"57","author":[{"given":"Jung-Won","family":"Suh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Pyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bon-Kwon","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Seok","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jin","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Ho","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ju","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Woon","family":"Rha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang-Ho","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taek-Geun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang-Whan","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong-Chan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2010.08.631_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjcard.2008.03.060","article-title":"Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention","volume":"102","author":"Solinas","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2010.08.631_bib2","first-page":"108","article-title":"Treatment of drug-eluting stent restenosis: an emerging challenge","volume":"74","author":"Aminian","year":"2009","journal-title":"Catheter Cardiovascular Interv"},{"key":"10.1016\/j.jacc.2010.08.631_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daewen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.08.631_bib4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jacc.2010.08.631_bib5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug-eluting stent versus bare-metal stents in Sweden","volume":"356","author":"Lagerqvist","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jacc.2010.08.631_bib6","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.08.631_bib7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jacc.2008.06.038","volume":"52","author":"Patti","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.08.631_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","article-title":"Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12 month follow-up","volume":"119","author":"Marcucci","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.08.631_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","article-title":"Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation","volume":"29","author":"Price","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2010.08.631_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcomes in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2010.08.631_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ncpcardio0660","article-title":"Established and evolving medical therapies for claudication in patients with peripheral arterial disease","volume":"3","author":"Regensteiner","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jacc.2010.08.631_bib12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/01.STR.0000221783.08037.a9","article-title":"Cilostazol protects against brain white matter damage and congnitive impairment in a rat model of chronic cerebral hypoperfusion","volume":"37","author":"Watanabe","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2010.08.631_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejphar.2009.06.016","article-title":"Cilostazol reduces proliferation through c-myc down-regulation in MDCK cells","volume":"616","author":"Mu\u00f1oz","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacc.2010.08.631_bib14","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.104.530097","article-title":"Coronary stent restenosis in patients treated with cilostazol","volume":"112","author":"Douglas","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.08.631_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jacc.2007.11.049","volume":"51","author":"Lee","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.08.631_bib16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.amjcard.2007.05.032","article-title":"Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial)","volume":"100","author":"Lee","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2010.08.631_bib17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4244\/V5I3A60","article-title":"Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomized trials","volume":"5","author":"Tamhane","year":"2009","journal-title":"Eurointervention"},{"key":"10.1016\/j.jacc.2010.08.631_bib18","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/eurheartj\/ehn287","article-title":"A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study","volume":"29","author":"Angiolillo","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2010.08.631_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jacc.2008.12.025","volume":"53","author":"Jeong","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.08.631_bib20","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jacc.2005.07.048","article-title":"Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis","volume":"46","author":"Lee","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.08.631_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ahj.2009.11.014","article-title":"Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: drug-eluting stenting followed by Cilostazol treatment Reduces Adverse Serious cardiac Events (DECREASE registry)","volume":"159","author":"Lee","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2010.08.631_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1745-6215-11-87","volume":"11","author":"Lee","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2010.08.631_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.thromres.2006.01.019","article-title":"Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk Assessment (VERITAS) study","volume":"119","author":"Malinin","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2010.08.631_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0143-4160(03)00170-2","article-title":"Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1","volume":"35","author":"Fox","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.jacc.2010.08.631_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis In Myocardial Infarction (TIMI) trial-phase 1: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.08.631_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(07)61295-1","article-title":"Effect of celecoxib on restenosis after coronary angioplasty with a TAXUS stent (COREA-TAXUS trial): an open-label randomized controlled study","volume":"370","author":"Koo","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.08.631_bib27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ahj.2009.01.006","article-title":"Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study","volume":"157","author":"Han","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2010.08.631_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.amjcard.2009.02.045","article-title":"Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans","volume":"104","author":"Lee","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2010.08.631_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1538-7836.2009.03319.x","article-title":"The CYP2C19*2 and CYP2C19*3 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome","volume":"7","author":"Kim","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2010.08.631_bib30","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","article-title":"Development of aspirin resistance in persons with previous ischemic stroke","volume":"25","author":"Helgason","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2010.08.631_bib31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jacc.2003.08.062","article-title":"Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients","volume":"43","author":"Pulcinelli","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.08.631_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/eurheartj\/ehi684","article-title":"Aspirin and clopidogrel resistance: an emerging clinical entity","volume":"27","author":"Wang","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2010.08.631_bib33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MCA.0b013e32832c4538","article-title":"Intensive lowering of blood pressure and low-density lipoprotein cholesterol with statin therapy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease","volume":"20","author":"Takamiya","year":"2009","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jacc.2010.08.631_bib34","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1161\/CIRCULATIONAHA.108.822791","article-title":"Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"119","author":"Chen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.08.631_bib35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ahj.2009.02.012","article-title":"Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial","volume":"157","author":"Price","year":"2009","journal-title":"Am Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109710044104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109710044104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:42:42Z","timestamp":1760013762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109710044104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0735109710044104"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2010.08.631","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2010.08.631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}